• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by RadNet Inc.

    2/8/23 4:13:30 PM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email
    SC 13G 1 RDNT2023.txt ANNUAL FILING 1 AS OF 12/31/2022 SEC 1745 (6-01) Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ___________)* RADNET, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) 750491102 12/31/22 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ X ]Rule 13d-1(b) [ ]Rule 13d-1(c) [ ]Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 750491102 1. Names of Reporting Persons Beck, Mack & Oliver LLC I.R.S. Identification Nos. of above persons (entities only). 13-0477010 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)........................................................................ b)........................................................................ 3.SEC Use Only ........................................................................... 4.Citizenship or Place of Organization New York Number of Shares Beneficially Owned by Each Reporting Person With 5.Sole Voting Power 3,222,494 6.Shared Voting Power 0 7.Sole Dispositive Power 3,222,494 8.Shared Dispositive Power 0 9.Aggregate Amount Beneficially Owned by Each Reporting Person 3,222,494 10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions 11.Percent of Class Represented by Amount in Row (9) 5.6% 12.Type of Reporting Person (See Instructions) IA Item 1. (a)Name of Issuer RADNET, INC. (b)Address of Issuer's Principal Executive Offices 1510 COTNER AVENUE LOS ANGELES, CALINFORNIA 90025 Item 2. (a)Name of Person Filing Beck, Mack & Oliver LLC (b)Address of Principal Business Office or, if none, Residence 565 Fifth Avenue New York, NY 10017 (c)Citizenship New York (d)Title of Class of Securities Common Stock (e)CUSIP Number 750491102 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a)[ ]Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b)[ ]Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c)[ ]Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d)[ ]Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). (e)[X ]An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f)[ ]An employee benefit plan or endowment fund in accordance with 240.13d- 1(b)(1)(ii)(F); (g)[ ]A parent holding company or control person in accordance with 240.13d- 1(b)(1)(ii)(G); (h)[ ]A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i)[ ]A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j)[ ]Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4.Ownership. Provide the following information regarding the aggregate number and Percentage of the class of securities of the issuer identified in Item 1. (a)Amount beneficially owned: 3,222,494 (b)Percent of class: 5.6% (c)Number of shares as to which the person has: (i)Sole power to vote or to direct the vote: 3,222,494 (ii)Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 3,222,494 (iv)Shared power to dispose or to direct the disposition of: 0 Instruction. For computations regarding securities which represent a right to acquire an underlying security see 240.13d3(d)(1). Item 5. Ownership of Five Percent or Less of a Class Not Applicable Item 6.Ownership of More than Five Percent on Behalf of Another Person. The securities covered by this statement are owned by investment advisory clients of Beck, Mack & Oliver LLC. These clients have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. No one of these clients own more than 5% of such class of securities. Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Not Applicable Item 8.Identification and Classification of Members of the Group Not Applicable Item 9.Notice of Dissolution of Group Not Applicable Item 10.Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. John C. Ellis SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 8, 2022 John C. Ellis Signature John C. Ellis, Co-Managing Member Name/Title
    Get the next $RDNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    8/12/2021Outperform → Market Perform
    Raymond James
    8/12/2021$39.00Overweight
    Barclays
    More analyst ratings

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Pres & COO-Eastern Operations Forthuber Stephen M converted options into 2,760 shares and sold $1,135,599 worth of shares (18,820 units at $60.34), decreasing direct ownership by 3% to 535,182 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      5/20/25 4:15:10 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Director Levitt Lawrence L sold $305,450 worth of shares (5,000 units at $61.09), decreasing direct ownership by 3% to 164,957 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      5/20/25 4:15:08 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Pres and COO-West Operations Hames Norman R converted options into 2,760 shares and sold $506,820 worth of shares (8,447 units at $60.00), decreasing direct ownership by 1% to 249,183 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      5/15/25 8:43:59 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Leadership Updates

    Live Leadership Updates

    See more
    • RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

      Former Chief Business Leader of Philips' multi-billion-dollar Precision Diagnosis division and member of Philips' Executive CommitteeEnd-to-end responsibility for Philip's CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businessesProven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appo

      9/12/24 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹

      First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditionsTotal Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024Total Company Adjusted EBITDA(1) was $4

      5/11/25 4:00:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. to Present at the Bank of America Securities 2025 Healthcare Conference on May 13th, 2025

      LOS ANGELES, May 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Bank of America Securities 2025 Healthcare Conference in Las Vegas, NV on Tuesday, May 13, 2025 at 5:00 p.m. Pacific Time. There will be simultaneous and archived webcasts available at https://bofa.veracast.com/webcasts/bofa/healthcare2025/id0NMyx8.cfm Details for RadNet's Presentation: Date:Tuesday, May 13, 2025Time:5:00 p.m. Pacific TimeLocat

      5/9/25 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 29, 2025 /PRNewswire/ -- Across the western healthcare landscape, artificial intelligence (AI) is being increasingly adopted to simplify authorizations and cut through layers of bureaucratic inefficiency. Rather than replacing physicians — a scenario some tech leaders like Bill Gates have speculated about — the goal is to enhance the capabilities of healthcare professionals. Momentum in this space is being driven by recent initiatives from companies like Avant Technologies, Inc. (OTCQB:AVAI), Koninklijke Philips N.V. (NYSE:PHG), HEALWELL AI Inc. (TSX:AIDX) (OTCQX:HWAIF), RadNet, Inc. (NASDAQ:RDNT)

      4/29/25 11:10:00 AM ET
      $ICAD
      $PHG
      $RDNT
      Medical/Dental Instruments
      Health Care
      Medical Electronics
      Medical Specialities

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RadNet upgraded by Raymond James with a new price target

      Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

      3/5/25 7:50:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Barclays with a new price target

      Barclays upgraded RadNet from Equal Weight to Overweight and set a new price target of $79.00 from $57.00 previously

      9/6/24 7:50:42 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • Barclays initiated coverage on RadNet with a new price target

      Barclays initiated coverage of RadNet with a rating of Equal Weight and set a new price target of $48.00

      3/6/24 8:01:30 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Financials

    Live finance-specific insights

    See more
    • RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹

      First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditionsTotal Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024Total Company Adjusted EBITDA(1) was $4

      5/11/25 4:00:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call

      LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its first quarter 2025 financial results on Monday, May 12, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet's conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1717619&tp_key=f0980d090d. An archived r

      4/24/25 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

      The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancerThe transaction is expected to add to RadNet's wholly owned subsidiary, DeepHealth, an installed base of over 1,500 healthcare provider locations across over 50 countriesWith iCAD's seasoned commercial and engineering team anticipated to join DeepHealth, the combination is expected to accelerate RadNet's growth and leadership in cancer screening and artificial intelligenceFollowing the completion of the acquisition, iCAD will be integrated into RadNet's DeepHealth portfolio of solutionsRadNet will host a conference call and

      4/15/25 4:01:37 PM ET
      $ICAD
      $RDNT
      Medical/Dental Instruments
      Health Care
      Medical Specialities

    $RDNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $RDNT
    SEC Filings

    See more
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      11/12/24 4:51:53 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      11/4/24 1:22:38 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      10/24/24 6:36:21 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form S-4/A filed by RadNet Inc.

      S-4/A - RadNet, Inc. (0000790526) (Filer)

      5/19/25 5:23:08 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form 425 filed by RadNet Inc.

      425 - RadNet, Inc. (0000790526) (Filed by)

      5/13/25 5:15:01 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by RadNet Inc.

      10-Q - RadNet, Inc. (0000790526) (Filer)

      5/12/25 4:09:52 PM ET
      $RDNT
      Medical Specialities
      Health Care